The global endoscopic ultrasonography (EUS) market is projected to reach USD 1.93 billion by 2029, growing from USD 1.37 billion in 2024 at a CAGR of 7.1%. This robust growth reflects the increasing adoption of EUS across the medical landscape, driven by the rising incidence of gastrointestinal (GI) disorders, advancements in minimally invasive procedures, and the integration of cutting-edge imaging technologies.
What is Endoscopic Ultrasonography (EUS)?
Endoscopic ultrasonography is a hybrid diagnostic and therapeutic technique that combines endoscopy with ultrasound. This dual capability provides detailed, high-resolution images of the digestive tract, surrounding tissues, and nearby organs.
EUS is widely used in the:
- Diagnosis of gastrointestinal and pancreatic diseases.
- Staging of cancers to determine disease progression.
- Guidance for therapeutic interventions such as biopsies, drainage, and ablation.
Healthcare professionals such as gastroenterologists, cardiologists, nephrologists, neurologists, hepatologists, and gynecologists utilize EUS to perform safe and precise examinations, improving clinical outcomes.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19121066
Market Growth Drivers
Several factors are fueling the growth of the EUS market:
- Rising Burden of GI Disorders and Cancers – Increasing cases of pancreatic, esophageal, and colorectal cancers are driving the demand for advanced imaging modalities.
- Growing Adoption of Minimally Invasive Procedures – Patients and providers prefer less invasive, accurate diagnostic tools that reduce recovery times.
- Technological Advancements – Integration of artificial intelligence (AI), high-definition imaging, and improved endoscope designs enhance diagnostic precision.
- Expanding Applications – Beyond GI disorders, EUS is finding applications in hepatology, pulmonology, and urology.
- Emerging Markets – Rapid healthcare infrastructure development in Asia-Pacific and Latin America presents untapped growth opportunities.
Key Players Shaping the Market
The endoscopic ultrasonography market is highly competitive, with global and regional players adopting strategies like product launches, partnerships, acquisitions, and geographic expansions.
Olympus Corporation (Japan)
Olympus is a market leader with an extensive EUS portfolio that includes GI and surgical endoscopes, endoscopic processors, and probes. The company emphasizes innovation, investing significantly in R&D for next-generation devices.
- Notable Innovation: In November 2023, Olympus launched the EVIS X1 system, its most advanced endoscopic platform, offering improved early diagnosis and minimally invasive treatments to enhance patient outcomes.
Medtronic (US)
Medtronic focuses on advanced ultrasound needles designed for diagnostic and therapeutic EUS procedures.
- Strategic Collaboration: In December 2023, Medtronic expanded its partnership with Cosmo Intelligent Medical Devices, enhancing the AI-powered GI Genius endoscopy module.
- With a global manufacturing and distribution network spanning 150+ countries, Medtronic ensures wide accessibility of its EUS innovations.
Boston Scientific Corporation (US)
Boston Scientific is recognized for its strong endoscopy portfolio across gastroenterology, pulmonary, and interventional bronchoscopy.
- Acquisition Move: In November 2022, it acquired Apollo Endosurgery, Inc., strengthening its minimally invasive technologies and expanding its reach in GI and pulmonary care.
- The company maintains a robust presence across the US, Asia-Pacific, and Europe, reinforcing its global market dominance.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=19121066
Other Prominent Companies
The market also features contributions from:
- FUJIFILM Holdings Corporation (Japan)
- PENTAX Medical (Japan)
- STERIS (Ireland)
- CONMED Corporation (US)
- Cook Medical (US)
- Canon Medical Systems Corporation (Japan)
- SonoScape Medical (China)
- Shaili Endoscopy (India)
- Medi-Globe GmbH (Germany)
...and several emerging players in China, India, and Israel, enhancing global competition with innovative and cost-effective solutions.
Future Outlook
The future of the endoscopic ultrasonography market looks promising with:
- Greater integration of AI and machine learning for real-time analysis and improved diagnostic accuracy.
- Development of single-use EUS devices to minimize cross-contamination risks and streamline clinical workflows.
- Expanding applications in oncology, hepatology, and cardiology, driving demand beyond traditional GI use cases.
- Growing investments in R&D and cross-industry collaborations to deliver cutting-edge technologies worldwide.
Conclusion
As the healthcare industry moves toward precision medicine and minimally invasive care, endoscopic ultrasonography is emerging as a cornerstone technology. With strong growth projections and innovations from leading players like Olympus, Medtronic, and Boston Scientific, the EUS market is poised to transform the way clinicians diagnose, stage, and treat complex conditions.
The next decade will see EUS devices becoming smarter, more accessible, and increasingly indispensable in global healthcare systems.
For more information, Inquire Now!
